We are live on
!
Find out more
US Bancorp Portfolio holdings
AUM
$91.6B
1-Year Est. Return
29.2%
This Fund
S&P 500
This Quarter
Est. Return
+2.77%
1 Year Est. Return
+29.2%
3 Year Est. Return
+76.81%
5 Year Est. Return
+86.62%
10 Year Est. Return
+295.59%
AUM
$30B
AUM Growth
+$778M
(+2.7%)
Cap. Flow
+$100M
Cap. Flow
% of AUM
0.33%
Top 10 Holdings %
Top 10 Hldgs %
23.18%
Holding
3,750
New
145
Increased
1,199
Reduced
1,328
Closed
155
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$33.8M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$25M |
| 3 |
Vanguard Real Estate ETF
VNQ
|
+$22.9M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$22.4M |
| 5 |
iShares MSCI EAFE ETF
EFA
|
+$20.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cardinal Health
CAH
|
+$30.2M |
| 2 |
VAL
Valspar
VAL
|
+$28.1M |
| 3 |
MBLY
Mobileye N.V.
MBLY
|
+$26.8M |
| 4 |
3M
MMM
|
+$17.9M |
| 5 |
Procter & Gamble
PG
|
+$16.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 29.33% |
| 2 | Industrials | 12.32% |
| 3 | Financials | 11.41% |
| 4 | Healthcare | 10.84% |
| 5 | Technology | 8.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Fresenius Medical Care
FMS
$12.1B
| $20.6M | 0.07% |
427,021
+40,121
| +10% | +$1.85M |
|
227
SAP
SAP
$248B
| $20.6M | 0.07% |
197,015
-7,565
| -4% | -$780K |
|
228
Zimmer Biomet
ZBH
$18.7B
| $20.6M | 0.07% |
165,341
-3,621
| -2% | -$429K |
|
229
Amphenol
APH
$204B
| $20.6M | 0.07% |
2,230,096
-1,352
| -0.1% | -$12.3K |
|
230
iShares Currency Hedged MSCI Japan ETF
HEWJ
$773M
| $20.6M | 0.07% |
689,755
+127,214
| +23% | +$3.66M |
|
231
Danaher
DHR
$146B
| $20.4M | 0.07% |
272,749
-5,200
| -2% | -$389K |
|
232
Stryker
SYK
$116B
| $20.3M | 0.07% |
145,934
-6,238
| -4% | -$856K |
|
233
Cummins
CMI
$77.2B
| $20.2M | 0.07% |
124,222
+3,879
| +3% | +$602K |
|
234
iShares MSCI USA Quality Factor ETF
QUAL
$47.5B
| $20M | 0.07% |
269,466
-16,158
| -6% | -$1.19M |
|
235
Sherwin-Williams
SHW
$81B
| $20M | 0.07% |
170,679
+25,629
| +18% | +$2.86M |
|
236
Valero Energy
VLO
$107B
| $19.9M | 0.07% |
294,341
-4,499
| -2% | -$292K |
|
237
Canadian National Railway
CNI
$74.6B
| $19.6M | 0.07% |
242,267
+1,994
| +0.8% | +$152K |
|
238
Becton Dickinson
BDX
$50.3B
| $19.6M | 0.07% |
103,118
+3,070
| +3% | +$561K |
|
|
MRSH
239
Marsh
MRSH
$88.6B
| $19.1M | 0.06% |
244,490
-6,367
| -3% | -$481K |
|
|
PXD
240
DELISTED
Pioneer Natural Resource Co.
PXD
| $18.9M | 0.06% |
118,744
-4,065
| -3% | -$695K |
|
|
CTRA
241
DELISTED
Coterra Energy
CTRA
| $18.8M | 0.06% |
751,522
+151,938
| +25% | +$3.59M |
|
242
Novartis
NVS
$304B
| $18.8M | 0.06% |
251,724
-98,034
| -28% | -$6.95M |
|
243
Lincoln National
LNC
$8.71B
| $18.8M | 0.06% |
277,799
-13,704
| -5% | -$906K |
|
244
Jack Henry & Associates
JKHY
$11.6B
| $18.6M | 0.06% |
179,251
-11,742
| -6% | -$1.17M |
|
245
Vanguard FTSE Developed Markets ETF
VEA
$240B
| $18.5M | 0.06% |
447,663
+32,503
| +8% | +$1.33M |
|
246
Baidu
BIDU
$33.7B
| $18.4M | 0.06% |
102,732
+14,083
| +16% | +$2.55M |
|
247
Aflac
AFL
$58.8B
| $18.4M | 0.06% |
473,026
-2,722
| -0.6% | -$102K |
|
248
Helmerich & Payne
HP
$4.43B
| $18.3M | 0.06% |
336,906
+33,852
| +11% | +$1.98M |
|
249
GSK
GSK
$100B
| $18.1M | 0.06% |
336,581
-26,450
| -7% | -$1.41M |
|
|
RDS.A
250
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $18.1M | 0.06% |
340,674
-7,574
| -2% | -$402K |
|
Similar funds
US Bancorp's Q2 2017 Portfolio in Review
As of Q2 2017, US Bancorp held 3,750 positions worth $30B, up 2.7% from $29.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
US Bancorp's Q2 2017 filing shows 145 new, 1,199 increased, 1,328 reduced and 155 closed positions. Its largest new stake was DXC Technology: 95,517 shares worth $6.34M. The largest sale was Cardinal Health, an estimated $30.2M.
By sector, the portfolio is most concentrated in Miscellaneous at 29% of assets, up from 28% a quarter earlier, followed by Industrials and Financials.
- US Bancorp's largest Q2 2017 buy was DXC Technology: 95,517 shares worth $6.34M.
- US Bancorp added most to iShares Core MSCI EAFE ETF in Q2 2017, an estimated $33.8M increase.
- US Bancorp's biggest Q2 2017 reduction was Cardinal Health, cutting an estimated $30.2M.
- US Bancorp fully exited Valspar in Q2 2017, selling an estimated $28.1M.
- US Bancorp's ten largest holdings make up 23% of its $30B portfolio in Q2 2017.
- US Bancorp opened 145 new positions and closed 155 in Q2 2017.
- US Bancorp's portfolio value rose 2.7% quarter-over-quarter to $30B.
Based on US Bancorp's 13F filing for Q2 2017, filed 20 Jul 2017.